OPPM
KBIO

Opus Point Partners Management’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

Opus Point Partners Management’s Portfolio KBIO Stock Details KBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-93,308
Closed -$358K – 68
2015
Q2 		$358K Hold
93,308
– – 0.28% 52
2015
Q1 		$366K Buy
93,308
+25,000
+37% +$112K 0.31% 61
2014
Q4 		$945K Buy
+68,308
New +$975K 0.94% 33

Other funds holding KBIO

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
OWIM
Old West Investment Management Los Angeles, California $944M AUM 90.26% 1-Year Est. Return

Opus Point Partners Management's KBIO Position: Q3 2015 in Review

Opus Point Partners Management sold out of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) in Q3 2015, closing a stake of 93,308 shares — an estimated $358K sold.

Opus Point Partners Management first reported a position in KBIO in Q4 2014 and held it in 3 quarters. The position peaked at $945K in Q4 2014. 14 funds tracked by Wall St. Rank hold KBIO as of Q3 2015.

  • Opus Point Partners Management reported no remaining KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position as of Q3 2015 after selling out during the quarter.
  • Opus Point Partners Management sold 93,308 KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) shares in Q3 2015, an estimated $358K.
  • Opus Point Partners Management first reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in Q4 2014 and held it in 3 quarters.
  • Opus Point Partners Management's KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position peaked at $945K in Q4 2014.
  • 14 funds tracked by Wall St. Rank held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) as of Q3 2015.

Based on Opus Point Partners Management's 13F filing for Q3 2015, filed 16 Nov 2015.